The rising prevalence of cancer across the globe further provide significant demand of live cell imaging that further contribute in the growth of the market. According to the World Health Organization (WHO), cancer is the second leading cause of mortality across the globe which is responsible for around 9.6 million mortalities and accounted for 18.1 million new cases in 2018, globally. 1 in 5 men and 1 in 6 women, worldwide, develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. Globally, the total number of people who are alive within 5 years of a cancer diagnosis, called the 5-year prevalence, is estimated to be 43.8 million. The live cell imaging is being used widely in the form of models to investigate disease mechanism and to develop therapies. The models based on 3D cell culture technology generates biological information in order to facilitate medical solutions promising preclinical drugs. 
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/live-cell-imaging-market
Technological development in cell culture technology spur the live cell imaging market
Cell-based assays have been widely used in drug discovery for the last several years. In the recent years, 2D monolayer cells cultured were the only convenient and effective means for drug discovery on a variety of planar substrates. Nowadays, 2D cell models are being very useful in drug discovery due to its efficient prediction in-vivo drug responses for many targets and pathways. However, the advent of 3D cell cultures is evident that these 2D cultures suffer disadvantages associated with the loss of tissue-specific architecture, cell-to-cell, and cell-to-matrix interactions, to predict drug responses for certain diseases such as cancer they are not suitable models. 3D cell cultures are being highly implemented in early drug discovery with the help of 3D high content screening (HCS), fueled by the need to continuously improve the productivity of pharmaceutical R&D. 
A Full Report of Global Live Cell Imaging Market is Available at: https://www.omrglobal.com/industry-reports/live-cell-imaging-market
The integration of cell models such as stem cells with 3D cell cultures allows enhanced predictability of toxicity in humans before the drugs are moved into clinical trials which in turn reduce the attrition rate of new medicines under development. Thus, the advanced diagnosis and drug development with 3D cell culture over the 2D cell culture is giving the edge to 3D cell culture which in turn, motivating the market growth for live cell imaging. Moreover, cancer research has progressed over recent years, and a new dimension of research has been discovered by the advent of 3D cell culture techniques. Cancer cell lines have been used to study the complex physiology of cancers due to ease and flexibility. With 3D cell culture techniques, there have been significant advancements in which the cell lines can be utilized to carry out cancer research. 
Global live cell imaging Market Segmentation
By Product
Instruments 
Consumables 
Software & Services
By Application
Stem Cells
Drug Discovery
Cell Biology
Others( Developmental Biology)
By End-User
Pharmaceutical & Biotechnology Companies
Research Institutes 
Contract Research Organizations
Global live cell imaging Market – Segment by Region 
North America           
United States 
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific    
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East and Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/live-cell-imaging-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +1 646-755-7667, +91 780-304-0404